The UnDruggable Series (@undruggable) 's Twitter Profile
The UnDruggable Series

@undruggable

The Undruggable Series hosts industry-leading forums in TPD, RNA & RAS, translating next generation small molecules to finally drug undruggable targets.

ID: 1341813669257220103

linkhttps://hansonwade.com/product/undruggable/ calendar_today23-12-2020 18:31:48

202 Tweet

955 Takipçi

193 Takip Edilen

The UnDruggable Series (@undruggable) 's Twitter Profile Photo

The Targeted Protein Degradation Europe Summit Returns to London on the 28th-30th of March 2023! Check out the brand new agenda here - ter.li/7vcsmr

The Targeted Protein Degradation Europe Summit Returns to London on the 28th-30th of March 2023! 

Check out the brand new agenda here - ter.li/7vcsmr
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

The Molecular Glue Drug Development Summit arrives this January 24-26, 2023. Register this week & save up to $800! View the agenda to see what's in store - ter.li/ivo7sc

The UnDruggable Series (@undruggable) 's Twitter Profile Photo

The 3rd TPD Europe Summit's biggest discount ends this Friday, 18th of November. Explore why you should be securing your place here - ter.li/cy5fly

Foghorn Therapeutics (@foghorntx) 's Twitter Profile Photo

Attending the inaugural @undruggable TPD Assay Development & Screening Summit? Watch Darshan Sappal’s presentation on assay development for optimization of effective #protein degraders. #science

Attending the inaugural @undruggable TPD Assay Development & Screening Summit? Watch Darshan Sappal’s presentation on assay development for optimization of effective #protein degraders. #science
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

In under 4 weeks, the 3rd TPD Europe Summit 2023 is coming to London. Hear the latest data from #PhoreMost, #Proteovant, #Novartis & many more exciting companies! View the latest brochure - ter.li/rug4iv

In under 4 weeks, the 3rd TPD Europe Summit 2023 is coming to London.

Hear the latest data from #PhoreMost, #Proteovant,  #Novartis & many more exciting companies!

View the latest brochure - ter.li/rug4iv
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

Unite with 80+ experts at the 2nd Hippo Pathway Summit this May 23-25! Explore why they are excited to be joining in the latest 2023 agenda -> ter.li/p0agu5

Unite with 80+ experts at the 2nd Hippo Pathway Summit this May 23-25!
Explore why they are excited to be joining in the latest 2023 agenda -> ter.li/p0agu5
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

Join 60+ Proximity Experts at the 3rd Induced Proximity-Based Drug Discovery Summit this July! Explore what our expert speakers will be presenting in the 2023 Agenda - ter.li/2nqwbj

Join 60+ Proximity Experts at the 3rd Induced Proximity-Based Drug Discovery Summit this July!

Explore what our expert speakers will be presenting in the 2023 Agenda - ter.li/2nqwbj
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

100+ TPD experts will share their latest insights at the 6th TPD Summit this October. Explore what they will be presenting here - ter.li/qsmcp2

Genomenon (@genomenon) 's Twitter Profile Photo

📢 4 weeks to go! Register now for Clinical Biomarkers & World CDx to secure your spot to hear Genomenon CSO Mark Kiel, MD, PhD talk with Susanne Rhoades from @LoxoLillyOnc and Tom Defay from Alexion about evolving approaches for harnessing the genomics of cancer. Info --> ter.li/v1uu7l

📢 4 weeks to go! Register now for <a href="/WorldCDx/">Clinical Biomarkers & World CDx</a> to secure your spot to hear Genomenon CSO <a href="/DrMarkKiel/">Mark Kiel, MD, PhD</a> talk with Susanne Rhoades from @LoxoLillyOnc and Tom Defay from <a href="/AlexionPharma/">Alexion</a>  about evolving approaches for harnessing the genomics of cancer. 

Info --&gt; ter.li/v1uu7l
Nurix Therapeutics (@nurix_tx) 's Twitter Profile Photo

We're excited to announce our strategic collaboration with @SeagenGlobal to develop a new class of drugs, Degrader Antibody-Conjugates (DACs). We’ll explore combining 2 approaches to treat cancer: antibody drug conjugation and targeted protein degradation. bit.ly/3L9p1WL

We're excited to announce our strategic collaboration with @SeagenGlobal to develop a new class of drugs, Degrader Antibody-Conjugates (DACs). We’ll explore combining 2 approaches to treat cancer: antibody drug conjugation and targeted protein degradation. bit.ly/3L9p1WL
The UnDruggable Series (@undruggable) 's Twitter Profile Photo

Just 2 weeks to go until 600+ TPD experts unite at the 6th Targeted Protein Degradation Summit! (October 30-November 2, 2023) Explore what our 110+ expert speakers will be sharing in the latest 2023 Agenda - ter.li/5ytgrl

Ingo Hartung (@hartungingo) 's Twitter Profile Photo

It was a proud moment yesterday when my colleague Marcel Rieker disclosed our #PROxAb shuttle technology at #TPD23 The UnDruggable Series. Along with the poster by Hendrik Schneider they outlined our plug-and-play platform for delivering VHL-based #PROTACs to diseased cells. Merck

It was a proud moment yesterday when my colleague Marcel Rieker disclosed our #PROxAb shuttle technology at #TPD23 <a href="/Undruggable/">The UnDruggable Series</a>. Along with the poster by Hendrik Schneider they outlined our plug-and-play platform for delivering VHL-based #PROTACs to diseased cells. <a href="/merckgroup/">Merck</a>
Ingo Hartung (@hartungingo) 's Twitter Profile Photo

Today I am going to talk about quality criteria for degrader probes at #TPD23 The UnDruggable Series. Small molecule degraders have great potential as drugs but also as tools to discover novel biology. But quality matters for all such tools. How to assess the quality of degrader probes?

Today I am going to talk about quality criteria for degrader probes at #TPD23 <a href="/Undruggable/">The UnDruggable Series</a>. Small molecule degraders have great potential as drugs but also as tools to discover novel biology. But quality matters for all such tools. How to assess the quality of degrader probes?